2021 Heart Failure Summit

The complexity of heart failure management is the focus of PCNA’s Virtual Heart Failure Summit, December 2, 2021. Heart failure is a chronic progressive disease affecting over 6.5 million Americans, and researchers expect the number to increase to eight million by the year 2030. Earn up to 2.25 continuing education contact hours when you join us in a deep dive into heart failure.

Agenda

8:00 AM CST	Welcome
8:10 AM CST	New and Emerging Treatments for HFrEF and HFpEF Colleen McIlvennan PhD, DNP, ANP, FAHA, FHFSA
9:00 AM CST	Treatment of Recurrent Pericarditis Kiniksa Product Theater Jane A. Linderbaum MS , ARNP, FACC
10:00 AM CST	Break
10:10 AM CST	Heart Failure and the Social Determinants of Health Part 1 Connie White-Williams, PhD, RN, NE-BC, FAAN
10:55 AM CST	Heart Failure and the Social Determinants of Health Part 2 Across Race and Gender Nancy M. Albert, RN, PhD, FHFSA
10:35 AM CST	Case-Based Management of Patients with Symptomatic Hypertrophic Cardiomyopathy Heidi Salisbury, RN, MS, CNS-BC, ACGN
12:25 PM CST	Wrap-up

Learning Objectives

New and Emerging Treatments for HFrEF and HFpEF (0.85 CE contact hours)

1. Review current guideline updates for heart failure management
2. Provide an update on new and emerging treatment options for HFrEF and HFpEF
3. Explain the role of SGLT2 inhibitors in heart failure management
4. Discuss the application of shared decision making in treatment options for HFrEF and HFpEF

Managing Heart Failure in Hypertrophic Cardiomyopathy (Non-CE)

1. Review the signs and symptoms of HCM, including diagnostic criteria
2. Describe the clinical relationship between hypertrophic cardiomyopathy (HCM) and heart failure (HF)
3. Discuss shared decision-making and treatment options for advanced HF in the HCM disease spectrum

Heart Failure and the Social Determinants of Health Part 1 (0.65 CE contact hours)

1. Define social determinants of health
2. Explain how the social determinants of health impact optimizing heart failure treatment
3. Discuss the interventions addressing the impact of the social determinants of health on delivery of care and outcomes of patients with heart failure

Heart Failure and the Social Determinants of Health Part 2 Deep Dive (0.65 CE contact hours)

1. Explore social detriments of health based on gender
2. Explore social detriments of health based on race
3. Discuss further interventions addressing improving delivery and outcomes of patients with heart failure

Supporters

Thank you to our event sponsors for help making this event possible:

• Novartis Pharmaceuticals Corporation
• Merck Sharpe & Dohme Corp.
• Bristol-Myers Squibb
• Kiniksa Pharmaceuticals

PCNA is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 03060